Skip to main content

Clene Inc.

Data quality: 100%
CLNN
Nasdaq Manufacturing Chemicals
$6.29
▼ $0.11 (-1.72%)
Mkt Cap: 74.09 M
Price
$6.29
Mkt Cap
74.09 M
Day Range
$6.15 — $6.44
52-Week Range
$2.28 — $13.50
Volume
55,679
Open $6.38
50D / 200D Avg
$5.02
25.38% above
50D / 200D Avg
$5.98
5.17% above

Quick Summary

Key Takeaways

Revenue declined -27.48% annually over 5 years
Negative free cash flow of -18.59 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 14.04%

Growth

Revenue Growth (5Y)
-27.48%
Below sector avg (1.82%)
Revenue (1Y)-41.52%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-127.72%
Net Margin-13086.50%
Op. Margin-11541.50%

Safety

Debt / Equity
N/A
Current Ratio1.53
Interest Coverage-8.61

Valuation

PE (TTM)
-2.83
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -2.8 -1.5
P/B 1.6
ROE % -53.5
Net Margin % -13086.5 -41.5
Rev Growth 5Y % -27.5 1.8
D/E 0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y) -41.52% Revenue Growth (3Y) -44.70%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -27.48% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 200,000.0 Net Income (TTM) -26.17 M
ROE N/A ROA -117.80%
Gross Margin N/A Operating Margin -11541.50%
Net Margin -13086.50% Free Cash Flow (TTM) -18.59 M
ROIC -127.72% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.53
Interest Coverage -8.61 Asset Turnover 0.01
Working Capital 4.37 M Tangible Book Value -12.36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.83 Forward P/E N/A
P/B Ratio N/A P/S Ratio 370.43
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -25.09%
Market Cap 74.09 M Enterprise Value 84.04 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.02
FCF / Share -1.58 OCF / Share -1.57
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 19.50% FCF Conversion 71.01%
SBC-Adj. FCF -25.79 M Growth Momentum -14.04

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 200,000.0 342,000.0 654,000.0 473,000.0 723,000.0
Net Income -26.17 M -39.40 M -49.50 M -29.92 M -9.74 M
EPS (Diluted)
Gross Profit
Operating Income -23.08 M -33.09 M -40.54 M -48.41 M -49.98 M
EBITDA
R&D Expenses 14.01 M 20.06 M 26.66 M 31.92 M 28.42 M
SG&A Expenses
D&A
Interest Expense 2.68 M 4.06 M 4.56 M -3.30 M 870,000.0
Income Tax 0.0 0.0 0.0 0.0 -428,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 18.13 M 27.34 M 52.34 M 44.49 M 63.06 M
Total Liabilities 35.72 M 36.19 M 38.95 M 41.26 M 50.47 M
Shareholders' Equity -17.59 M -8.86 M 13.39 M 3.24 M 12.60 M
Total Debt 17.79 M
Cash & Equivalents 5.19 M 12.16 M 28.82 M 18.33 M 50.35 M
Current Assets 8.98 M 16.16 M 38.85 M 29.20 M 54.58 M
Current Liabilities 10.78 M 10.29 M 25.33 M 13.86 M 6.03 M